Drug Approval | November 22, 2023
Truqap plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
Evinova will operate as a separate health-tech business within AstraZeneca
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
The company has raised US$4.5 million in funding for its AI operating system
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Subscribe To Our Newsletter & Stay Updated
